These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26398718)

  • 1. Impact of Roux-en-Y Gastric Bypass Surgery on Pharmacokinetics of Administered Drugs: Implications and Perspectives.
    Srinivas NR
    Am J Ther; 2016; 23(6):e1826-e1838. PubMed ID: 26398718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic considerations in Roux-en-Y gastric bypass patients.
    Smith A; Henriksen B; Cohen A
    Am J Health Syst Pharm; 2011 Dec; 68(23):2241-7. PubMed ID: 22095812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery.
    Krieger CA; Cunningham JL; Reid JM; Langman LJ; Grothe KB; Clark MM; Dierkhising RA
    Pharmacotherapy; 2017 Nov; 37(11):1374-1382. PubMed ID: 28845898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of gastric bypass surgery on drug absorption and pharmacokinetics.
    Brocks DR; Ben-Eltriki M; Gabr RQ; Padwal RS
    Expert Opin Drug Metab Toxicol; 2012 Dec; 8(12):1505-19. PubMed ID: 22998066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RYGB and Drug Disposition: How to Do Better? Analysis of Pharmacokinetic Studies and Recommendations for Clinical Practice.
    Hachon L; Declèves X; Faucher P; Carette C; Lloret-Linares C
    Obes Surg; 2017 Apr; 27(4):1076-1090. PubMed ID: 28124236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proximal Roux-en-Y gastric bypass alters drug absorption pattern but not systemic exposure of CYP3A4 and P-glycoprotein substrates.
    Chan LN; Lin YS; Tay-Sontheimer JC; Trawick D; Oelschlager BK; Flum DR; Patton KK; Shen DD; Horn JR
    Pharmacotherapy; 2015 Apr; 35(4):361-9. PubMed ID: 25757445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Roux-en-Y Gastric Bypass Surgery in Morbidly Obese Patients on Pharmacokinetics of (Acetyl)Salicylic Acid and Omeprazole: the ERY-PAO Study.
    Mitrov-Winkelmolen L; van Buul-Gast MW; Swank DJ; Overdiek HWPM; van Schaik RHN; Touw DJ
    Obes Surg; 2016 Sep; 26(9):2051-2058. PubMed ID: 26797705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Roux-En-Y Gastric Bypass in the Pharmacokinetics of (R)-Carvedilol and (S)-Carvedilol.
    Yamamoto PA; Cristofoletti R; Vozmediano V; de Gaitani CM; da Silva RM; Kemp R; Sankarankutty AK; Salgado Junior W; Santos JSD; de Moraes NV
    J Clin Pharmacol; 2023 Jul; 63(7):838-847. PubMed ID: 36854819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calorie restriction is a major determinant of the short-term metabolic effects of gastric bypass surgery in obese type 2 diabetic patients.
    Lips MA; de Groot GH; van Klinken JB; Aarts E; Berends FJ; Janssen IM; Van Ramshorst B; Van Wagensveld BA; Swank DJ; Van Dielen F; Willems van Dijk K; Pijl H
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):834-42. PubMed ID: 23711328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Roux-en-Y gastric bypass on the bioavailability of metoprolol from immediate and controlled release tablets: a single oral dose study before and after surgery.
    Yska JP; Wanders JTM; Odigie B; Apers JA; Emous M; Totté ERE; Boerma EC; Ubels FL; Woerdenbag HJ; Frijlink HW; Wilffert B; van Roon EN
    Eur J Hosp Pharm; 2020 Mar; 27(e1):e19-e24. PubMed ID: 32296500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary comparison of sertraline levels in postbariatric surgery patients versus matched nonsurgical cohort.
    Roerig JL; Steffen K; Zimmerman C; Mitchell JE; Crosby RD; Cao L
    Surg Obes Relat Dis; 2012; 8(1):62-6. PubMed ID: 21256091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Obesity and Roux-En-Y Gastric Surgery on Omeprazole Pharmacokinetics.
    Portolés-Pérez A; Paterna ABR; Sánchez Pernaute A; Torres García AJ; Moreno Lopera C; Chicharro LM; Bandrés F; López-Picado A; Rubio MA; Castrillón EV
    Obes Facts; 2022; 15(2):271-280. PubMed ID: 34979510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Warfarin Dosages and International Normalized Ratios Before and After Roux-en-Y Gastric Bypass Surgery.
    Steffen KJ; Wonderlich JA; Erickson AL; Strawsell H; Mitchell JE; Crosby RD
    Pharmacotherapy; 2015 Sep; 35(9):876-80. PubMed ID: 26406775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution.
    Darwich AS; Pade D; Ammori BJ; Jamei M; Ashcroft DM; Rostami-Hodjegan A
    J Pharm Pharmacol; 2012 Jul; 64(7):1008-24. PubMed ID: 22686346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissolution of common psychiatric medications in a Roux-en-Y gastric bypass model.
    Seaman JS; Bowers SP; Dixon P; Schindler L
    Psychosomatics; 2005; 46(3):250-3. PubMed ID: 15883146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid and body weight-independent improvement of endothelial and high-density lipoprotein function after Roux-en-Y gastric bypass: role of glucagon-like peptide-1.
    Osto E; Doytcheva P; Corteville C; Bueter M; Dörig C; Stivala S; Buhmann H; Colin S; Rohrer L; Hasballa R; Tailleux A; Wolfrum C; Tona F; Manz J; Vetter D; Spliethoff K; Vanhoutte PM; Landmesser U; Pattou F; Staels B; Matter CM; Lutz TA; Lüscher TF
    Circulation; 2015 Mar; 131(10):871-81. PubMed ID: 25673670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year weight loss after primary or revisional Roux-en-Y gastric bypass for failed adjustable gastric banding.
    Topart P; Becouarn G; Ritz P
    Surg Obes Relat Dis; 2009; 5(4):459-62. PubMed ID: 18996766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrostomy tube placement in gastric remnant at gastric bypass: a rat model for selective gut stimulation.
    Eldar S; Heneghan HM; Dan O; Kirwan JP; Schauer PR; Brethauer SA
    Surg Obes Relat Dis; 2013; 9(3):442-6. PubMed ID: 22301091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients.
    Tandra S; Chalasani N; Jones DR; Mattar S; Hall SD; Vuppalanchi R
    Ann Surg; 2013 Aug; 258(2):262-9. PubMed ID: 23222033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.